1.44
-0.02 (-1.37%)
| Previous Close | 1.46 |
| Volume | 381,667 |
| Price / Earnings (Forward) | 31.75 |
| Price / Sales | 266.31 |
| Price / Book | 1.44 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.640 |
| Total Debt/Equity (MRQ) | 0.48% |
| Current Ratio (MRQ) | 16.19 |
| Operating Cash Flow (TTM) | -9.28 M |
| Levered Free Cash Flow (TTM) | -5.26 M |
| Return on Assets (TTM) | -40.06% |
| Return on Equity (TTM) | -66.48% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | Microbot Medical Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot’s LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Institutions | 6.26% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |